INTERNATIONAL PATENT: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD., 石药集团中奇制药技术（石家庄）有限公司 FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDE FOR INHIBITING TRPV1 GENE EXPRESSION AND USE THEREOF"

GENEVA, March 24 -- CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (No. 896, Zhongshan East Road, High-tech ZoneShijiazhuang, Hebei 050035), 石药集团中奇制药技术（石家庄）有限公司 (中国河北省石家庄市高新区中山东路896号) filed a patent application (PCT/CN2024/119093) for "ANTISENSE OLIGONUCLEOTIDE FOR INHIBITING TRPV1 GENE EXPRESSION AND USE THEREOF" on Sep 14, 2024. With publication no. WO/2025/056059, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application w...